Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
MEDI7183 low dose
MEDI7183 medium dose
+2 more
Locations
23
Japan
Research Site
Chikushino-shi, Japan
Research Site
Fujiidera-shi, Japan
Research Site
Fukuyama-shi, Japan
Research Site
Hamamatsu, Japan
Research Site
Kagoshima, Japan
Research Site
Kamakura-shi, Japan
Start Date
November 21, 2013
Primary Completion Date
August 11, 2015
Completion Date
April 10, 2018
Last Updated
July 5, 2019
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions